Bongiovanni, Gabriele
Tonutti, Antonio
Stainer, Anna
Nigro, Mattia
Kellogg, Dean L III
Nambiar, Anoop
Gramegna, Andrea
Mantero, Marco
Voza, Antonio
Blasi, Francesco
Aliberti, Stefano
Amati, Francesco https://orcid.org/0000-0002-8248-7785
Clinical trials referenced in this document:
Documents that mention this clinical trial
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
https://doi.org/10.1136/bmjresp-2023-002161
Documents that mention this clinical trial
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
https://doi.org/10.1136/bmjresp-2023-002161
Documents that mention this clinical trial
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review
https://doi.org/10.1136/bmjresp-2023-002161
Funding for this research was provided by:
This work was partially supported by “Ricerca Corrente” funding from Italian Ministry of Health to IRCCS Humanitas Research Hospital.